跳至主要内容
临床试验/NCT02857231
NCT02857231已完成不适用

Bioimpedance Spectroscopy Compared to CardioMEMS™ Determined Pulmonary Artery Pressure Measurements

ImpediMed Limited1 个研究点 分布在 1 个国家目标入组 16 人开始时间: 2017年8月7日最近更新:
适应症

试验速览

阶段
不适用
状态
已完成
入组人数
16
试验地点
1
主要终点
Change from baseline in bioimpedance measurement at 4 weeks

研究概览

简要总结

Comparison of changes in diastolic pulmonary artery pressure as measured by CardioMEMS™ to impedance parameters as measured by ImpediMed's BIS technology.

详细描述

This is a prospective, single-arm, observational, non-randomized clinical study that will enroll patients with heart failure who have had a CardioMEMS™ device implanted to monitor their diastolic pulmonary artery pressure. The study will recruit and enroll ten participants from the Scripps Clinic. Participants will be monitored 3 times a week for a period of 4 weeks. At each monitoring visit, the patient's diastolic pulmonary artery pressure will be measured by CardioMEMS™ and the ImpediMed's BIS technology. Participant's vital signs and weight will also be taken at each monitoring visit.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • has an CardioMEMs device implanted
  • has been diagnosed with various stages of heart failure as described by New York Heart Association (NYHA)
  • is able to give informed consent

排除标准

  • has pacemaker/ICD
  • is pregnant or breastfeeding
  • is an amputee
  • has been diagnosed with multiple medical conditions that would make participation burdensome
  • not able to co-operate with impedance measurements

结局指标

主要结局

Change from baseline in bioimpedance measurement at 4 weeks

时间窗: Baseline and 4 weeks

Change in impedance values will be tracked from baseline for 4 weeks and compared to CardioMEMS measures

次要结局

未报告次要终点

研究者

申办方类型
Industry
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验